C O M M U N I C A T I O N S
Scheme 2. Transition-State Model and Removal of SO2
Table 2. Chiral Ligand Screeninga
equiv of
ligand
yieldb
(%)
entry
Cu(OTf)2
(equiv)
%eec
ERc
1
2
3
4
5
6
7
8
9
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.15
0.05
0.2
(R,R)-10a (0.2)
(S,S)-10b (0.2)
(S,S)-10c (0.2)
(S,S)-11a (0.2)
(R,R)-11a (0.2)
(S,S)-11b (0.2)
(R,R)-11c (0.2)
(R,S)-12 (0.2)
(R,R)-13 (0.2)
(R,R)-11a (0.15)
(R,R)-11a (0.05)
(R,R)-11a (0.2)
54
53
73
75
85
50
55
<5
18
64
34
72
24
14
28
86
92
24
82
-
62:38
43:57
36:64
7:93
96:4
38:62
91:9
-
80-94% ee.6 The 2-sulfamido thiophene substrate 14 reacted very
sluggishly but with good enantioselectivity. N-Tosyl-2-allylaniline
16 reacted efficiently but with low (46%) enantioselectivity, and
N-tosyl-2-allylbenzylamine 18 reacted sluggishly and in moderate
yield and enantioselectivity to provide tetrahydroisoquinoline 19
(entry 12).
X-ray crystal structures of sultams 2g and 15 indicate the S
configuration. The other carboamination adducts in Table 3 are
assigned the S stereochemistry by analogy. Sultam 2i was converted
to the known 2(S)-benzylpyrrolidine 20,7 an intermediate used in
the synthesis of a potent calcium-sensing receptor antagonist,8 by
reductive removal of SO2 (Scheme 2). Pyrrolidine (S)-20 is thus
available by this method in three steps from commercially available
starting materials (see Supporting Information for complete details).
The observed stereochemistry is consistent with transition state
A (Scheme 2), where the substrate’s N-substituent is on the face
opposite of the oxazoline phenyl substituent it is cis to about the
distorted square planar copper center.4
4
48:52
96:4
-
10
11
12d
92
-
94
97:3
a Reaction conditions: Cu(OTf)2 and ligand were combined, dissolved
in PhCF3 (0.1 M w/r to 1a) and heated at 50 °C for 1 h. Substrate 1a,
MnO2 (3 equiv), and K2CO3 (1 equiv) were added, and the reaction tube
was sealed and heated at 120 °C for 24 h unless otherwise noted. b Yield
refers to amount of isolated 2a after purification by flash chromatography
on SiO2. c Enantiomeric excess and ratios (ER) were determined by chiral
HPLC analysis (Chiralcel OD-H). d Reaction was run at 110 °C.
Table 3. Scope of Enantioselective Carboamination with
(R,R)-11aa
The method reported herein provides access to enantiomerically
enriched nitrogen heterocycles. Applications of this reaction toward
the synthesis of bioactive compounds are underway. This method
will also inspire the development of other copper(II)-catalyzed
enantioselective amination reactions.
Acknowledgment. The financial support of the NIH/NIGMS
RO1 GM078383 is gratefully acknowledged. Dr. Shao-Liang Zheng
(SUNY, Buffalo X-ray crystallography facility) is gratefully
acknowledged for obtaining crystal structures of 2g and 15.
Supporting Information Available: Experimental procedures,
compound characterization data, X-ray structures with determination
of absolute configuration, and HPLC traces with determination of
enantiomeric excess. This material is available free of charge via the
References
(1) (a) Larock, R. C.; Yang, H.; Weinreb, S. M.; Herr, R. J. J. Org. Chem.
1994, 59, 4172. (b) Harayama, H.; Abe, A.; Sakado, T.; Kimura, M.;
Fugami, K.; Tanaka, S.; Tamaru, Y. J. Org. Chem. 1997, 62, 2113. (c)
Sherman, E. S.; Chemler, S. R.; Tan, T. B.; Gerlits, O. Org. Lett. 2004,
6, 1573. (d) Yip, K.-T.; Yang, M.; Law, K.-L.; Zhu, N.-Y.; Yang, D. J.
Am. Chem. Soc. 2006, 128, 3130. (e) Scarborough, C. C.; Stahl, S. S.
Org. Lett. 2006, 8, 3251. (f) Sherman, E. S.; Fuller, P. H.; Kasi, D.;
Chemler, S. R. J. Org. Chem. 2007, 72, 3896. (g) Peng, J.; Lin, W.; Yuan,
S.; Chen, Y. J. Org. Chem. 2007, 72, 3145. (h) Bertrand, M. B.; Leathen,
M. L.; Wolfe, J. P. Org. Lett. 2007, 9, 457. (i) Wolfe, J. P. Eur. J. Org.
Chem. 2007, 571 and references therein. (j) Nakhla, J. S.; Wolfe, J. P.
Org. Lett. 2007, 9, 3279.
(2) (a) Sammes, P. G. In ComprehensiVe Medicinal Chemistry; Hansch, C.,
Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press; Oxford, 1990; Vol.
2, Chapter 7.1. (b) Wilkening, R. R.; Ratcliffe, R. W.; Wildonger, K. J.;
Cama, L. D.; Dykstra, K. D.; DiNinno, F. P.; Blizzard, T. A.; Hammond,
M. L.; Heck, J. V.; Dorso, K. L.; Rose, E. St.; Kohler, J.; Hammond, G.
G. Bioorg. Med. Chem. Lett. 1999, 9, 673.
a Reaction conditions: Cu(OTf)2 (0.2 equiv) and (R,R)-11a (0.2 equiv)
were combined and treated with PhCF3 (0.1 M w/r to substrate) and heated
at 50 °C for 1 h. Substrate (1 equiv), MnO2 (3 equiv), and K2CO3 (1 equiv)
were added, and the reaction tube was sealed and heated at 120 °C for 24
h unless otherwise noted. All reactions were run at least two times to ensure
reproducibility. b Yields refer to amount isolated after purification by flash
chromatography on SiO2. c Enantiomeric excess and ratios were determined
by chiral HPLC analysis (Chiralcel OD-H or AD-RH). d Reactions were
run for 96 h.
(Table 2, entry 12). Ligands 12 and 13 rendered the copper(II)
complex less reactive (entries 8 and 9).
(3) Chemler, S. R.; Fuller, P. H. Chem. Soc. ReV. 2007, 36, 1153 and
references therein.
(4) Johnson, J. S.; Evans, D. A. Acc. Chem. Res. 2000, 33, 325.
(5) Kwong, F. Y.; Buchwald, S. L. Org. Lett. 2003, 5, 793.
(6) A homologue of 1a, one carbon longer in the chain, did not react.
(7) Burgess, L. E.; Meyers, A. I. J. Org. Chem. 1992, 57, 1656.
(8) Yang, W.; Wang, Y.; Roberge, J. Y.; Ma, Z.; Liu, Y.; Lawrence, R. M.;
Rotella, D. P.; Seethala, R.; Feyen, J. H.; Dickson, J. K. Bioorg. Med.
Chem. Lett. 2005, 15, 1225.
The generality of the reaction was examined as shown in Table
3. γ-Alkenyl arylsulfonamides 1 cyclized in 45-85% yield and
JA0762240
9
J. AM. CHEM. SOC. VOL. 129, NO. 43, 2007 12949